Tag Archives: biotech


Enveda Raised $311 Million Series E at a $2 Billion Valuation:

September 24, 2026 : Permalink

HedgeCo.Net — AI-native drug discovery company Enveda closed a $311 million Series E on September 23, 2026 at a $2 billion valuation led by Catalio Capital Management, according to… Continue reading →

Biotech Rallies: Composite Models Take Advantage

April 23, 2015 : Permalink

New York (HedgeCo.net)  – The biotech sector has been on an incredible run over the last four years and so far in 2015, the rally has continued. In the last four years, the iShares Nasdaq Biotechnology ETF (NYSE: IBB) has gone […]